These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 6315424
1. In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa. Angehrn P. Eur J Clin Microbiol; 1983 Oct; 2(5):489-95. PubMed ID: 6315424 [Abstract] [Full Text] [Related]
5. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections. Maslow MJ, Simberkoff MS, Rahal JJ. J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125 [Abstract] [Full Text] [Related]
6. Cefoxitin: synergism with aminoglycosides in vitro. Une T, Osada Y, Ogawa H. Arzneimittelforschung; 1981 Aug; 31(5):761-4. PubMed ID: 6791664 [Abstract] [Full Text] [Related]
10. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. Washington JA, Snyder RJ, Kohner PC, Wiltse CG, Ilstrup DM, McCall JT. J Infect Dis; 1978 Feb; 137(2):103-11. PubMed ID: 415096 [Abstract] [Full Text] [Related]
11. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)]. Schassan HH. Infection; 1976 Feb; 4(2):35-41. PubMed ID: 789246 [Abstract] [Full Text] [Related]
12. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Kluge RM, Standiford HC, Tatem B, Young VM, Greene WH, Schimpff SC, Calia FM, Hornick RB. Antimicrob Agents Chemother; 1974 Oct; 6(4):442-6. PubMed ID: 4157342 [Abstract] [Full Text] [Related]
13. [Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci]. Linda H, Patzer J. Med Dosw Mikrobiol; 1984 Oct; 36(4):223-9. PubMed ID: 6100122 [No Abstract] [Full Text] [Related]
14. Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin. Machka K, Dietz R. Eur J Clin Microbiol; 1983 Oct; 2(5):496-500. PubMed ID: 6315425 [Abstract] [Full Text] [Related]
15. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance]. Reynaud AE, Coude du Foresto B, Derriennic M, Courtieu AL. Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424 [Abstract] [Full Text] [Related]
16. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium]. Christe M, Vaudaux P, Waldvogel FA. Schweiz Med Wochenschr; 1982 Feb 13; 112(7):234-41. PubMed ID: 6803358 [Abstract] [Full Text] [Related]
17. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ]. Kosakai N, Oguri T. Jpn J Antibiot; 1975 Aug 13; 28(4):530-7. PubMed ID: 240047 [Abstract] [Full Text] [Related]
19. In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics. Kelly MT, Matsen JM. Antimicrob Agents Chemother; 1976 Mar 13; 9(3):440-7. PubMed ID: 1259402 [Abstract] [Full Text] [Related]
20. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin. Knothe H. J Infect Dis; 1976 Nov 13; 134 SUPPL():S271-4. PubMed ID: 825585 [Abstract] [Full Text] [Related] Page: [Next] [New Search]